EMA Authorised: PritorPlus (telmisartan;hydrochlorothiazide) — Bayer AG

View source ↗

Summary

EMA authorised PritorPlus, a fixed-dose combination of telmisartan and hydrochlorothiazide, for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• PritorPlus (telmisartan/hydrochlorothiazide)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: Bayer AG. Decision date: 07/01/2025